Wednesday, January 08, 2025

12:00PM – 1:00PM ET

Please note this TeleECHO program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.

PRESENTING FACULTY

David E. Gerber, MD Professor, Department of Internal Medicine Division of Hematology and Oncology Harold C. Simmons Comprehensive Cancer Center University of Texas Southwestern Medical Center Dallas, TX

PROGRAM OVERVIEW

This virtually live educational program is designed to educate healthcare professionals on the evidence-based implementation of immune checkpoint inhibitors into the management of patients with non-small cell lung cancer (NSCLC). A special emphasis will be placed on how to optimize this care across a multidisciplinary and community-based oncology care team, using a patient-centered approach guided by shared decision making.

TARGET AUDIENCE

This activity is designed to meet the educational needs of community-based medical oncologists, oncology nurses, pharmacists, nurse practitioners and other members of the multidisciplinary team to maintain an up-to-date understanding of the latest data on immune checkpoint inhibitor regimens in the management of NSCLC.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Review immunotherapy clinical trials findings in the first-line setting for patients with advanced NSCLC
• Utilize updated treatment guidelines in the management of patients with advanced NSCLC without actionable drivers
• Recognize the most common IO-related adverse events and their management in patients with NSCLC
• Integrate routine communication across the oncology care team and with the patient to optimize shared decision making and involvement in overall care plan development

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture the faculty may mention the use of medications for both US Food and Drug Administration (FDA)-approved and non-FDA-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science-based.

This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]